Recommendations for Prevention and Control of Influenza in Children, 2019-2020

Area of Science:

• Pediatrics
• Infectious Diseases
• Vaccinology

Background:

• Influenza poses a significant health risk to children annually.
• The American Academy of Pediatrics (AAP) provides guidance on influenza prevention and treatment.
• Updated recommendations are crucial for the 2019-2020 influenza season.

Purpose of the Study:

• To update the AAP's recommendations for routine influenza vaccination in children.
• To provide guidance on the use of antiviral medications for influenza treatment in pediatric populations.
• To emphasize the importance of influenza prevention strategies for children.

Main Methods:

• Review of current influenza vaccine and antiviral medication data.
• Formulation of evidence-based recommendations for pediatric influenza management.
• Consideration of age-appropriateness and contraindications for vaccines and treatments.

Main Results:

• Routine influenza immunization is recommended for all children aged 6 months and older without contraindications.
• No preference is given to specific licensed, age-appropriate influenza vaccine products.
• Antiviral treatment is recommended for children with suspected or confirmed influenza, particularly those with severe disease or risk factors.

Conclusions:

• Annual influenza vaccination remains a cornerstone of pediatric influenza prevention.
• Prompt antiviral treatment is crucial for managing influenza in at-risk children.
• Adherence to updated AAP guidelines ensures optimal influenza control in pediatric populations.